Abb Ltd
OTC:ABBNY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Abb Ltd
OTC:ABBNY
|
CH |
|
A
|
Amada Co Ltd
OTC:AMDLY
|
JP |
|
C
|
Captor Therapeutics SA
WSE:CTX
|
PL |
|
C
|
Chemring Group PLC
DUS:CMN1
|
UK |
|
Atlantic Sapphire ASA
F:4AS
|
NO |
|
O
|
Oil and Gas Development Co Ltd
LSE:37OC
|
PK |
|
M
|
Minor International PCL
SET:MINT
|
TH |
Wall St Price Targets
ABBNY Price Targets Summary
Abb Ltd
According to Wall Street analysts, the average 1-year price target for ABBNY is 96.17 USD with a low forecast of 54.03 USD and a high forecast of 122.8 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABBNY's stock price target?
Price Target
96.17
USD
According to Wall Street analysts, the average 1-year price target for ABBNY is 96.17 USD with a low forecast of 54.03 USD and a high forecast of 122.8 USD.
What is the Revenue forecast for Abb Ltd?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 8 years is 10%.
What is the Gross Profit forecast for Abb Ltd?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 5 years is 11%.
What is the Operating Income forecast for Abb Ltd?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 5 years is 12%.
What is the Pre-Tax Income forecast for Abb Ltd?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 12%.
What is the Net Income forecast for Abb Ltd?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 5 years is 11%.
